ReviewJournal of multidisciplinary healthcare2025
Pharmacist-Led Digital Health Interventions to Improve Treatment Outcomes in Patients with Hypertension - A Systematic Review.
Review in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the advancement of digital technologies, pharmacist-led digital health interventions (DHI) have emerged as a promising strategy to improve hypertension management. This systematic review evaluated randomized controlled trials (RCTs) published from December 1996 to May 2024, identified via PubMed by incorporating key concepts including DHIs, pharmaceutical care, and hypertension. The review included RCTs assessed telephone-, web-, or mobile-based pharmacist-led DHI compared to usual care (UC). Primary outcomes included blood pressure (BP) reduction, medication adherence, and identification of drug-related problems (DRPs). Following the modified Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, fourteen RCTs met inclusion criteria, with interventions categorized as telephone monitoring (n = 6), web-based interventions (n = 5), and mobile-based interventions (n = 3). Eight studies (57.14%) showed significant BP reduction in the intervention group (IG), one (7.14%) reported diastolic blood pressure (DBP) reduction only, and one found no significant BP difference between IG and control group (CG). One study reported a higher BP control rate in the IG (OR = 3.64). All studies evaluating adherence (n = 5) showed improvements, and one reported enhanced DRP identification. We identified that interventions' effectiveness is influenced by frequency of the intervention, personalization, and patient engagement. Designing an intervention compatible with each patient and providing sufficient guidance may improve effectiveness. As most studies were conducted in high-income countries, further research is needed to ensure the applicability of DHIs in diverse settings. In conclusion, pharmacist-led DHIs demonstrate potential in improving hypertension outcomes, with further validation required to support their implementation across varied healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.